Chiara Pane

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans

Genki Hayashi, Mittal Jasoliya, Sunil Sahdeo et al. · Human Molecular Genetics · 2017 · 129 citations · Full text

Multiple Sclerosis Patients, Mitochondrial Biogenesis, Mitochondrial Function +11

A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design

Francesco Saccà, Giorgia Puorro, Antonella Antenora et al. · PLoS ONE · 2011 · 68 citations · Full text

The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests

Francesco Saccà, Teresa Costabile, Antonio Carotenuto et al. · Multiple Sclerosis Journal · 2016 · 62 citations

Brain Structure and Degeneration Staging in Friedreich Ataxia: <scp>Magnetic Resonance Imaging</scp> Volumetrics from the <scp>ENIGMA‐Ataxia</scp> Working Group

Ian H. Harding, Sidhant Chopra, Filippo Arrigoni et al. · Annals of Neurology · 2021 · 59 citations · Full text